FUJIFILM Diosynth Biotechnologies Breaks Ground on Biopharmaceutical Production Complex
FUJIFILM Diosynth Biotechnologies broke ground in October of 2021 on a $2 billion production facility in Holly Springs, N.C. Enabling large-scale cell culture manufacturing for the creation of bulk drug substances, the structure will accommodate eight 20,000-liter bioreactors with the expansion potential for a further 24 20,000-liter bioreactors to meet market demand. Powered by clean energy, the sustainably designed complex will feature advanced systems for waste disposal and recycling.